Portage Biotech Stock Price on November 15, 2024
PRTG Stock | USD 4.13 0.10 2.48% |
If you're considering investing in Portage Stock, it is important to understand the factors that can impact its price. As of today, the current price of Portage Biotech stands at 4.13, as last reported on the 7th of December, with the highest price reaching 4.20 and the lowest price hitting 3.95 during the day. Portage Biotech is extremely dangerous given 3 months investment horizon. Portage Biotech maintains Sharpe Ratio (i.e., Efficiency) of 0.0899, which implies the firm had a 0.0899% return per unit of risk over the last 3 months. We were able to interpolate and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.52% are justified by taking the suggested risk. Use Portage Biotech Semi Deviation of 6.91, risk adjusted performance of 0.0762, and Coefficient Of Variation of 1112.05 to evaluate company specific risk that cannot be diversified away.
Portage Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Portage |
Sharpe Ratio = 0.0899
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | PRTG | |||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
16.87 actual daily | 96 96% of assets are less volatile |
Expected Return
1.52 actual daily | 30 70% of assets have higher returns |
Risk-Adjusted Return
0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Portage Biotech is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Portage Biotech by adding it to a well-diversified portfolio.
Related Headline
Fennec Pharmaceuticals Headline on 15th of November 2024
Disposition of 400000 shares by Hackman Jeffrey S. of Fennec... by Hackman Jeffrey S.
Filed transaction by Fennec Pharmaceuticals Director, Officer Chief Executive Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Portage Biotech Valuation on November 15, 2024
It is possible to determine the worth of Portage Biotech on a given historical date. On November 15, 2024 Portage was worth 4.14 at the beginning of the trading date compared to the closed value of 4.09. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Portage Biotech stock. Still, in general, we apply an absolute valuation method to find Portage Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Portage Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Portage Biotech's related companies.
Open | High | Low | Close | Volume | |
4.19 | 4.22 | 3.80 | 3.95 | 31,280 | |
11/15/2024 | 4.14 | 4.41 | 3.97 | 4.09 | 18,318 |
3.80 | 4.18 | 3.80 | 4.04 | 29,759 |
Backtest Portage Biotech | | | Portage Biotech History | | | Portage Biotech Valuation | Previous | Next |
Portage Biotech Trading Date Momentum on November 15, 2024
On November 18 2024 Portage Biotech was traded for 4.04 at the closing time. The top price for the day was 4.18 and the lowest listed price was 3.80 . The trading volume for the day was 29.8 K. The trading history from November 18, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.22% . The trading delta at closing time against the current closing price is 7.33% . |
Portage Biotech Fundamentals Correlations and Trends
By evaluating Portage Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Portage Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Portage financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Portage Biotech Stock history
Portage Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Portage is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Portage Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Portage Biotech stock prices may prove useful in developing a viable investing in Portage Biotech
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. It also provides Nanolipogel co-formulation platform for delivery of DNA aptamers and certain aptamer-small molecule-based combination products and STING agonist platform, a proprietary immune priming and boosting technology, offers various ways to target immune stimulation towards the cancer, as well as to co-deliver various signals in a single product. Portage Biotech is traded on NASDAQ Exchange in the United States.
Portage Biotech Stock Technical Analysis
Portage Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Portage Biotech Period Price Range
Low | December 7, 2024
| High |
0.00 | 0.00 |
Portage Biotech cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Portage Biotech December 7, 2024 Market Strength
Market strength indicators help investors to evaluate how Portage Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Portage Biotech shares will generate the highest return on investment. By undertsting and applying Portage Biotech stock market strength indicators, traders can identify Portage Biotech entry and exit signals to maximize returns
Portage Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Portage Biotech's price direction in advance. Along with the technical and fundamental analysis of Portage Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Portage to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0762 | |||
Jensen Alpha | 1.56 | |||
Total Risk Alpha | (1.47) | |||
Sortino Ratio | 0.1761 | |||
Treynor Ratio | (3.62) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Portage Stock analysis
When running Portage Biotech's price analysis, check to measure Portage Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Portage Biotech is operating at the current time. Most of Portage Biotech's value examination focuses on studying past and present price action to predict the probability of Portage Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Portage Biotech's price. Additionally, you may evaluate how the addition of Portage Biotech to your portfolios can decrease your overall portfolio volatility.
Global Correlations Find global opportunities by holding instruments from different markets | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Commodity Directory Find actively traded commodities issued by global exchanges |